A message from Batavia Biosciences’ Executive Management Menzo Havenga and Chris Yallop about COVID-19:
As a company at the forefront of vaccine development, epidemic preparedness and active in the fight against COVID-19, Batavia Biosciences remains fully operational. We have taken actions to ensure the safety of our employees and visitors whilst continuing to execute our projects. We are in active dialogue with our suppliers to ensure supply chain and shipment continuity. We continue to monitor the situation so we can respond quickly with further contingency plans in the event this is necessary.
In the current situation, we are confident Batavia is well positioned to continue operations with minimal impact. If you have any questions in relation to our COVID-19 preparedness or more generally, please do not hesitate to contact us at email@example.com.
We appreciate your understanding and hope everyone stays healthy and safe in these turbulent times.
Menzo Havenga and Chris Yallop